Service of Infectious Diseases, University Hospital Geneva, 4 Rue Gabrielle-Perret-Gentil, Geneva 14, Switzerland.
Thorax. 2010 Aug;65(8):703-10. doi: 10.1136/thx.2009.133082.
Pseudomonas aeruginosa frequently colonises intubated patients and causes life-threatening ventilator-associated pneumonia (VAP). The role of quorum sensing (QS), regulating virulence in this pathogen, during colonisation and development of VAP is unknown.
P aeruginosa isolates and tracheal aspirates were prospectively collected from intubated patients. Genotypes and QS-independent virulence traits (exoU, exoS, PAPI-1 and PAPI-2) harboured by colonising isolates were identified in vitro with the CLONDIAG array. The production of elastase and rhamnolipids was measured to assess QS-dependent virulence. To monitor QS activity 'in patient', total RNA was extracted directly from tracheal aspirates and expression of QS genes was measured.
320 P aeruginosa isolates and tracheal aspirates were obtained from 29 patients of whom 6 developed VAP (20%). Seven patients (24%) were initially colonised by QS-proficient isolates; 57% of them developed VAP as compared with 9% of patients colonised by QS-deficient isolates (p=0.018). Of all tested virulence traits from the initial colonising isolates, only rhamnolipids were associated with development of VAP (p=0.003). VAP occurred more frequently in patients colonised during the entire observation period by isolates producing high levels of rhamnolipids (p=0.001). 'In patient' monitoring of QS genes showed non-induced expression profiles in patients without VAP. In contrast, exponential induction of QS circuit and target gene expression was observed for two patients with VAP, and an 'in patient' QS gene expression profile and hierarchy similar to those in vitro was measured for one patient with VAP.
Production of the QS-dependent virulence factor rhamnolipids by colonising P aeruginosa isolates is associated with development of VAP.
铜绿假单胞菌常定植于插管患者,引起危及生命的呼吸机相关性肺炎(VAP)。群体感应(QS)在该病原体定植和 VAP 发展过程中调节毒力的作用尚不清楚。
前瞻性收集插管患者的铜绿假单胞菌分离株和气管吸出物。使用 CLONDIAG 阵列在体外鉴定定植分离株携带的基因型和 QS 独立的毒力特征(exoU、exoS、PAPI-1 和 PAPI-2)。测量弹性蛋白酶和鼠李糖脂的产生来评估 QS 依赖性毒力。为了监测“患者体内”的 QS 活性,直接从气管吸出物中提取总 RNA,并测量 QS 基因的表达。
从 29 名患者中获得了 320 株铜绿假单胞菌分离株和气管吸出物,其中 6 名患者发展为 VAP(20%)。7 名患者(24%)最初定植于 QS 阳性分离株;与 QS 缺陷分离株定植的患者中 9%发生 VAP 相比,发生 VAP 的患者比例为 57%(p=0.018)。在所有初始定植分离株的测试毒力特征中,只有鼠李糖脂与 VAP 的发展相关(p=0.003)。定植期间产生高水平鼠李糖脂的分离株定植的患者 VAP 更频繁(p=0.001)。在没有 VAP 的患者中,“患者体内”监测 QS 基因显示非诱导表达谱。相比之下,对于两名发生 VAP 的患者,观察到 QS 电路和靶基因表达的指数诱导,并且对于一名发生 VAP 的患者,测量到与体外相似的“患者体内”QS 基因表达谱和层次结构。
定植铜绿假单胞菌分离株产生 QS 依赖性毒力因子鼠李糖脂与 VAP 的发展相关。